Evidence map›Paper›PMID 40607633›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2025

Efficacy of the 4 Subclasses of IgG for Interacting With CD32b/a on Human Basophils.

Donald MacGlashan, Benjamin W Spiller, Scott A Smith

Abstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Donald MacGlashanDivision of Allergy and Clinical Immunology, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0003-4525-0452
Benjamin W SpillerMicrobiology and Immunology and Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0001-5397-1028
Scott A SmithDepartments of Medicine and Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Comprehensive antigenic mapping of the human anti-peanut IgE antibody responseR01AI155668 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SCOTT ALAN · 2021 to 2025
$4.1M
Regulation of Syk Expression in Human BasophilsR01AI163043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MACGLASHAN, DONALD W · 2021 to 2024
$1.6M
Generation and characterization of full-length naturally occurring allergen-specific human IgE mAbsR21AI123307 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SCOTT ALAN · 2017 to 2018
$408k
CTSA UL1TR000445NCATS NIH HHS UL1 TR000445NIAID NIH HHS R01 AI155668NIAID NIH HHS R01 AI163043NIAID NIH HHS R21 AI123307NIH HHS R21AI123307NIH HHS RO1AI155668NIH HHS RO1AI163043Vanderbilt University Discovery Grant
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40607633
PMCPMC12416374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.